Top compounds associated with response to TTC4


Feature Type Standardized
Nominal ANOVA
mRNA AZ-3146 CTRPv2 pan-cancer AAC -0.062 0.08
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.062 0.08
mRNA BRD6340 CTRPv2 pan-cancer AAC 0.061 0.08
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.055 0.09
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.059 0.09
mRNA pac-1 CTRPv2 pan-cancer AAC -0.062 0.09
mRNA CAL-101 CTRPv2 pan-cancer AAC -0.062 0.09
mRNA thapsigargin gCSI pan-cancer AAC 0.094 0.09
mRNA FGIN-1-27 CTRPv2 pan-cancer AAC -0.12 0.1
mRNA HLI 373 CTRPv2 pan-cancer AAC -0.06 0.1
Download CSV